Erik Szabó / White Unicorn — the venture-building layer
The “translation into a viable company” layer that sits alongside, not inside, the research and clinical stack. He brings the builder layer this ecosystem most lacks: company building, early capital, and market access alongside research and clinical validation.
Core framing line. “A talented researcher is not an ecosystem.” The bottleneck is translation, not invention.
Positions
Managing Director / CEO and founder of White Unicorn Health/Medtech Incubator and co-founder of Goroid Venture Studio — investor, incubator, and product-development partner in one.
Track record
- Scaling and exit. Late-stage founder of the digital agency Carnation, which grew to 120+ people, won 100+ local and international awards (clients including Adidas, Aston Martin, Coca-Cola), and was acquired by WPP, the world’s largest agency network (profile).
- Industry institution-building. Former board member of the Hungarian Advertising Association; founder of the Hungarian chapter of IAB (bio).
- Investor experience. Angel investor after the exit; one portfolio company listed on the Budapest Stock Exchange’s XTEND market.
- Engineering foundation. MSc in computer engineering, University of Veszprém, 1999 (interview, HU).
Capital
White Unicorn won HUF 250M from NKFIH’s Startup Factory programme, topped up with private capital to HUF 284M, for 10–15 early-stage startups (NKFIH, project page). Typical ticket: HUF 20–30M, with co-investment for larger clinical steps (Growth Magazin).
Relevant portfolio
As translation templates, not as this ecosystem’s own output:
- Theia Labs — AI-based ophthalmic image diagnostics.
- Auxiliis Biomarker — biomarkers plus software interpretation in rheumatoid arthritis.
Both are templates for digital, biomarker-based clinical decision support (portfolio).
Existing network
Technology-transfer offices at the universities of Szeged, Pécs, Debrecen and Pannonia; co-investors including HunBAN, Lunar Program and Gateway Ventures; MDR/FDA service providers already in-network (ecosystem). Connecting ELTE and Semmelweis would extend this network toward psychiatry specifically.
The five-test screen
His project-evaluation framework, directly reusable here:
| Test | Question |
|---|---|
| Clinical problem | Is there a real, named clinical problem? |
| Workflow fit | Does it fit how clinicians actually work? |
| Evidence plan | Is there a credible plan to generate evidence? |
| Regulatory path | Is the MDR route understood? |
| Adoption model | Who pays, and why would they adopt it? |
These apply directly to speech- and behaviour-based digital biomarkers and to the Argus Cognitive case. → Clinical AI translation
International focus
In his view, Hungarian medtech should be built from the start to attract international strategic partners (Startup Online, HU) — a match for the Copenhagen and Sorbonne connections in this ecosystem.
Proposed roles
- Workshop. Innovation-perspective speaker; closing-roundtable “market reality” voice. Talk: “Building a MedTech Ecosystem.” In-person participation confirmed.
- Ecosystem. Venture-building and investment partner, startup screening, team-building (CEO / product lead), capital connections — not a research or clinical role.
Disambiguation. The Hungarian White Unicorn (whiteunicorn.hu) is not the Indian investor White Unicorn Ventures.
Related pages
Argus Cognitive · Clinical AI translation · Funding landscape · INNOFAIR workshop programme